AcuamarkDx Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

AcuamarkDx General Information

Description

Developer of a cancer screening blood technology designed to detect cancer markers at early stages. The company's technology integrates a suite of novel, multiplexed assays that test for several levels of molecular change through frequent, recurrent, sequential monitoring and screening, enabling doctors to get a scalable and economical blood-based screening result for early detection of cancer, heart disease, thyroid function, and diabetes.

Contact Information

Formerly Known As
iCareDx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 Avenue Of The Americas
  • 3rd Floor (care of JLabs)
  • New York, NY 10013
  • United States
+1 (646)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 101 Avenue Of The Americas
  • 3rd Floor (care of JLabs)
  • New York, NY 10013
  • United States
+1 (646)

AcuamarkDx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AcuamarkDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Apr-2026 Completed Clinical Trials - Phase 4
8. Later Stage VC (Series A2) 04-Jun-2024 Completed Clinical Trials - Phase 4
7. Later Stage VC (Series A) 06-Apr-2022 Completed Clinical Trials - Phase 4
6. Accelerator/Incubator 01-Jan-2020 Completed Clinical Trials - Phase 4
5. Later Stage VC (Series AA) 15-Dec-2019 Completed Pre-Clinical Trials
4. Angel (individual) 31-Dec-2018 Completed Pre-Clinical Trials
3. Early Stage VC (Series AA) 27-Dec-2017 Completed Pre-Clinical Trials
2. Early Stage VC (Series A1) 16-Nov-2016 $1.6M $1.6M Completed Startup
1. University Spin-Out 16-Oct-2012 Completed Startup
To view AcuamarkDx’s complete valuation and funding history, request access »

AcuamarkDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series AA3
Series AA2
Series AA1
Series A1 2,563,115 $0.000100 $1.33 $1.33 1x $1.33 6.69%
Series A 10,000,000 $0.000100 $1.67 $1.67 1x $1.67 26.11%
To view AcuamarkDx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AcuamarkDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cancer screening blood technology designed to detect cancer markers at early stages. The company's techno
Biotechnology
New York, NY
8 As of 2026

Madison, WI
 

Palo Alto, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AcuamarkDx Competitors (23)

One of AcuamarkDx’s 23 competitors is Exact Sciences, a Formerly VC-backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exact Sciences Formerly VC-backed Madison, WI
Delfi Diagnostics Venture Capital-Backed Palo Alto, CA
GRAIL Formerly VC-backed Menlo Park, CA
CellMax Life Venture Capital-Backed Sunnyvale, CA
Freenome Formerly VC-backed Brisbane, CA
You’re viewing 5 of 23 competitors. Get the full list »

AcuamarkDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AcuamarkDx Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
1955 Capital Venture Capital Minority
Bruker Corporation Minority
HBS Alumni Angels of Greater New York Angel Group Minority
XLerateHealth Accelerator/Incubator
Cornell University University
To view AcuamarkDx’s complete investors history, request access »

AcuamarkDx FAQs

  • When was AcuamarkDx founded?

    AcuamarkDx was founded in 2012.

  • Where is AcuamarkDx headquartered?

    AcuamarkDx is headquartered in New York, NY.

  • What is the size of AcuamarkDx?

    AcuamarkDx has 8 total employees.

  • What industry is AcuamarkDx in?

    AcuamarkDx’s primary industry is Biotechnology.

  • Is AcuamarkDx a private or public company?

    AcuamarkDx is a Private company.

  • What is AcuamarkDx’s current revenue?

    The current revenue for AcuamarkDx is .

  • How much funding has AcuamarkDx raised over time?

    AcuamarkDx has raised $25M.

  • Who are AcuamarkDx’s investors?

    1955 Capital, Bruker, HBS Alumni Angels of Greater New York, XLerateHealth, and Cornell University have invested in AcuamarkDx.

  • Who are AcuamarkDx’s competitors?

    Exact Sciences, Delfi Diagnostics, GRAIL, CellMax Life, and Freenome are some of the 23 competitors of AcuamarkDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process